Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0309 | 1 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0074 | 0.1286 | 0.1223 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0159 | 0.4417 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0159 | 0.4417 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0159 | 0.4417 | 0.5 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0309 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0159 | 0.4417 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0074 | 0.1286 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0159 | 0.4417 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0119 | 0.2946 | 0.6669 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0159 | 0.4417 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0159 | 0.4417 | 1 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0074 | 0.1286 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0159 | 0.4417 | 1 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0309 | 1 | 1 |
Entamoeba histolytica | iron-sulfur flavoprotein, putative | 0.004 | 0 | 0.5 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0074 | 0.1286 | 0.5 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0159 | 0.4417 | 1 |
Onchocerca volvulus | 0.0074 | 0.1286 | 0.1223 | |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0074 | 0.1286 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0159 | 0.4417 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0159 | 0.4417 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0159 | 0.4417 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0159 | 0.4417 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0074 | 0.1286 | 0.1223 |
Onchocerca volvulus | 0.0268 | 0.8457 | 0.8446 | |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0074 | 0.1286 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0074 | 0.1286 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0159 | 0.4417 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0309 | 1 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0159 | 0.4417 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0159 | 0.4417 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0074 | 0.1286 | 0.1223 |
Brugia malayi | Kringle domain containing protein | 0.0074 | 0.1286 | 0.1223 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0159 | 0.4417 | 0.5 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0074 | 0.1286 | 0.1223 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0159 | 0.4417 | 1 |
Onchocerca volvulus | 0.0309 | 1 | 1 | |
Entamoeba histolytica | modulator of drug activity B homolog, putative | 0.004 | 0 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0042 | 0.0072 | 0.5 |
Toxoplasma gondii | kringle domain-containing protein | 0.0074 | 0.1286 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0159 | 0.4417 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 71 % | Phytotoxicity in Oryza sativa (rice) assessed as assessed as growth rate at 30 g/acre by Oryza sativa (rice) injury assay | ChEMBL. | No reference |
Activity (functional) | = 91 % | Phytotoxicity in Oryza sativa (rice) assessed as assessed as growth rate at 10 g/acre by Oryza sativa (rice) injury assay | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.